Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zengerling

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Der Urologe. Ausg. A|August 5, 2016
[German national second-opinion network for testicular cancer and penile carcinoma : Two sources for evidence-based information]M Schrader, F Zengerling, O W Hakenberg, et al.
Der Urologe. Ausg. A|April 21, 2015
[Secondary prevention in patients with superficial urothelial carcinoma]T J Schnöller, F Zengerling, C Hirning, et al.
Der Urologe. Ausg. A|October 12, 2012
[Male sexuality in the elderly]L Rinnab, A J Schrader, M Schrader, et al.
Aktuelle Urologie|July 20, 2011
[Diagnostic relevance of choline-PET / CT in patients with prostate cancer]F Zengerling, A J Schrader, M Schrader, et al.
Der Urologe. Ausg. A|August 22, 2014
[Organ-sparing therapy for testicular cancer]C Breunig, M Schrader, A J Schrader, et al.
Der Urologe. Ausg. A|August 28, 2013
[Clinical stage I seminoma. Is surveillance a new therapy standard?]F Zengerling, J Müller, A J Schrader, et al.
Der Urologe. Ausg. A|July 18, 2012
[Guidelines: reality and quality]S Rogenhofer, F Zengerling, M Schrader, et al.
Aktuelle Urologie|April 15, 2016
[Recent Therapy of Organ-confined Testis Cancer]C Breunig, F Zengerling, T Schnöller, et al.
Der Urologe. Ausg. A|February 24, 2012
[Value of positron emission tomography in urological neoplasms: more form than substance?]J Müller, M Schrader, A J Schrader, et al.
British Journal of Cancer|November 22, 2012
Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancerB Nitzsche, C Gloesenkamp, M Schrader, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Der Urologe. Ausg. A|August 5, 2016
[German national second-opinion network for testicular cancer and penile carcinoma : Two sources for evidence-based information]M Schrader, F Zengerling, O W Hakenberg, et al.
Der Urologe. Ausg. A|April 21, 2015
[Secondary prevention in patients with superficial urothelial carcinoma]T J Schnöller, F Zengerling, C Hirning, et al.
Der Urologe. Ausg. A|October 12, 2012
[Male sexuality in the elderly]L Rinnab, A J Schrader, M Schrader, et al.
Aktuelle Urologie|July 20, 2011
[Diagnostic relevance of choline-PET / CT in patients with prostate cancer]F Zengerling, A J Schrader, M Schrader, et al.
Der Urologe. Ausg. A|August 22, 2014
[Organ-sparing therapy for testicular cancer]C Breunig, M Schrader, A J Schrader, et al.
Der Urologe. Ausg. A|August 28, 2013
[Clinical stage I seminoma. Is surveillance a new therapy standard?]F Zengerling, J Müller, A J Schrader, et al.
Der Urologe. Ausg. A|July 18, 2012
[Guidelines: reality and quality]S Rogenhofer, F Zengerling, M Schrader, et al.
Aktuelle Urologie|April 15, 2016
[Recent Therapy of Organ-confined Testis Cancer]C Breunig, F Zengerling, T Schnöller, et al.
Der Urologe. Ausg. A|February 24, 2012
[Value of positron emission tomography in urological neoplasms: more form than substance?]J Müller, M Schrader, A J Schrader, et al.
British Journal of Cancer|November 22, 2012
Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancerB Nitzsche, C Gloesenkamp, M Schrader, et al.
Pageof 3